Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Aldeyra Therapeutics, Inc. (ALDX)

« Back to company index

ALDX Chatter Timeline

Stock Ticker for ALDX

Most Active Tweeters for ALDX

UserTweets
@Tickeron 7
@TonyFauci2 6
@FlashAlert_me 4
@MarcJacksonLA 4
@StockNewsBot2 3

Recent Tweets for ALDX

TonyFauci2 @TonyFauci2
@GZuckerman @bradloncar Edelman was largest $ALDX backer
May 26th 2022, 6:05pm
ChartMill @ChartMill
$ALDX was analyzed by 16 analysts. The buy consensus is at 88%. So analysts seem to be very confident about $ALDX.… https://t.co/95z6MaeqFH
May 26th 2022, 4:05pm
TonyFauci2 @TonyFauci2
@brendan_49 NOT arguing -just perplexed ? $ALDX claims better technology supports redness endpoint- no? https://t.co/jF1zyeS2Cx
May 26th 2022, 3:05pm
TonyFauci2 @TonyFauci2
@brendan_49 Changing primary endpoints late in a trial never seems to be a harbinger of positive results - that’s what $ALDX just did. Why?
May 25th 2022, 8:05pm
TonyFauci2 @TonyFauci2
$ALDX changed Primary Tranquilty 2 endpoint Again “The primary endpoint of the upcoming P3 TRANQUILITY-2 Trial has… https://t.co/RPd3hk0Pcg
May 25th 2022, 6:05am
MaisaCorp @MaisaCorp
$ALDX Aldeyra Therapeutics Designates Schirmer Test As Sole Primary Endpoint In Phase 3 Tranquility-2 Trial Of Reproxalap In Dry Eye Disease
May 24th 2022, 9:05pm
Tickeron @Tickeron
$ALDX in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/r44fnWZG72
May 24th 2022, 7:05pm
Tickeron @Tickeron
How do you think the market will react to this? $ALDX Aroon Indicator entered a Downtrend. #AldeyraTherapeutics… https://t.co/ogg1NyAoSV
May 24th 2022, 6:05pm
MarcJacksonLA @MarcJacksonLA
$ALDX Berenberg Bank Initiates Coverage On Aldeyra Therapeutics With A Buy Rating, $28 PT https://t.co/xKruSlBFiq
May 24th 2022, 6:05pm
Quantumup1 @Quantumup1
@MattBiotech I'm sticking with this $ALDX tweet And How did Zhang keep from cracking up from this video you tweet… https://t.co/m7QrDglVxV
May 24th 2022, 4:05pm
firebutworking @firebutworking
RT @MattBiotech: History of $ALDX primary sign: - Reduction of RASP and we inhibit RASP, easy peasy - Hm, this might be harder to measure a…
May 24th 2022, 4:05pm
MattBiotech @MattBiotech
History of $ALDX primary sign: - Reduction of RASP and we inhibit RASP, easy peasy - Hm, this might be harder to me… https://t.co/INWbhVeSqv
May 24th 2022, 4:05pm
TonyFauci2 @TonyFauci2
@brendan_49 My point is - in Tranquilty $ALDX did a clinical assessment of redness - as all practitioners who may u… https://t.co/cyjxAedzkA
May 24th 2022, 2:05pm
MarcJacksonLA @MarcJacksonLA
$ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/lzg5DyMLoz
May 24th 2022, 1:05pm
ItsTurk73 @ItsTurk73
$ALDX https://t.co/cobCr3ruru
May 24th 2022, 1:05pm
otcdynamics @otcdynamics
$ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/VbSn5YtKzd
May 24th 2022, 11:05am
UCSCTweetBot @UCSCTweetBot
RT @stock_titan: $ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap…
May 24th 2022, 11:05am
FlashAlert_me @FlashAlert_me
$ALDX [15s. delayed]: Issued Press Release on May 24, 07:00:00: Aldeyra Therapeutics Designates Schirmer Test as So… https://t.co/bIxaTsIdIb
May 24th 2022, 11:05am
investor_feed @investor_feed
$ALDX 8-K Aldeyra Therapeutics (24 May, 7:05am) ? Other Events; Financial Statements and Exhibits… https://t.co/85gCWeRsUv
May 24th 2022, 11:05am
FlashAlert_me @FlashAlert_me
$ALDX [15s. delayed] filed form 8-K on May 24, 07:05:43 https://t.co/GTCw7J8xHx
May 24th 2022, 11:05am
Market_Newswire @Market_Newswire
$ALDX SEC Filing: 8-K Other Events - Aldeyra Therapeutics, Inc. (0001341235) May 24 https://t.co/KXh1Z1zXIM
May 24th 2022, 11:05am
bkfViking123 @bkfViking123
RT @BioStocks: $ALDX Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Disease. To…
May 24th 2022, 11:05am
BioStocks @BioStocks
$ALDX Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Dis… https://t.co/Azgu3WpoAO
May 24th 2022, 11:05am
firebutworking @firebutworking
$ALDX Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Disease
May 24th 2022, 11:05am
StockNewsBot2 @StockNewsBot2
$ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/lxRcJQqzfr
May 24th 2022, 11:05am
UCSCTweetBot @UCSCTweetBot
RT @FastestAlert: $ALDX Aldeyra Therapeutics Designates Schirmer Test As Sole Primary Endpoint In Phase 3 TRANQUILITY-2 Trial Of Reproxalap…
May 24th 2022, 11:05am
FastestAlert @FastestAlert
$ALDX Aldeyra Therapeutics Designates Schirmer Test As Sole Primary Endpoint In Phase 3 TRANQUILITY-2 Trial Of Repr… https://t.co/SmO1gqw8oP
May 24th 2022, 11:05am
stock_titan @stock_titan
$ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/qAJXMP9LaY
May 24th 2022, 11:05am
WebChronicleTo1 @WebChronicleTo1
$ALDX Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Repr… https://t.co/8UtMmS64gZ
May 24th 2022, 11:05am
1stOncology @1stOncology
#AldeyraTherapeutics to Present at H.C. Wainwright Global #InvestmentConference $ALDX https://t.co/ZyaaTda72S
May 24th 2022, 7:05am
quant_alert @quant_alert
$aldx Earnings reports today before the markets open.. https://t.co/BZqdgc4iXB
May 24th 2022, 2:05am
Tickeron @Tickeron
$ALDX's Aroon indicator drops into Downtrend on May 20, 2022. View odds for this and other indicators:… https://t.co/DEAbh5dUU1
May 23rd 2022, 11:05pm
newsfilterio @newsfilterio
Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference $ALDX https://t.co/Ny2PYF0YGO
May 23rd 2022, 10:05pm
MC_OptionTrades @MC_OptionTrades
$ALDX 17-Jun-22 Straddle Implies a ±27.3% move. May 24 H.C. Wainwright Global Investment Conference https://t.co/gWaapsJb9W
May 23rd 2022, 9:05pm
otcdynamics @otcdynamics
$ALDX Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/pA40ePVsRR
May 23rd 2022, 8:05pm
FlashAlert_me @FlashAlert_me
$ALDX [15s. delayed]: Issued Press Release on May 23, 16:05:00: Aldeyra Therapeutics to Present at H.C. Wainwright… https://t.co/Mtqo1Qe93X
May 23rd 2022, 8:05pm
StockNewsBot2 @StockNewsBot2
$ALDX Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/EPbltuIFoV
May 23rd 2022, 8:05pm
FastestAlert @FastestAlert
$ALDX Aldeyra Therapeutics To Present At H.C. Wainwright Global Investment Conference Stock News Alerts In Bio
May 23rd 2022, 8:05pm
WebChronicleTo1 @WebChronicleTo1
$ALDX Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/EhvKOlRu60
May 23rd 2022, 8:05pm
stock_titan @stock_titan
$ALDX Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/CCh4McwQRw
May 23rd 2022, 8:05pm
bthefirsttoknow @bthefirsttoknow
First out// $ALDX: Aldeyra Therapeutics to Present at H.C. Wainwright Global Investment Conference https://t.co/8c56PI4s3p
May 23rd 2022, 8:05pm
OwenMar54200817 @OwenMar54200817
$ALDX Top Analyst price target today https://t.co/2izrP1g81o
May 23rd 2022, 6:05pm
TonyFauci2 @TonyFauci2
Why Bother? $ALDX - Embarrassing https://t.co/1jJhIGmLYm
May 23rd 2022, 5:05pm
Geary_Enoch @Geary_Enoch
$ALDX For a limited time we are opening our trading chatroom for public,,,,, https://t.co/hl8yIRno89
May 21st 2022, 12:05pm
AlertTrade @AlertTrade
REVERSALtoUP: $ALDX Aldeyra Therapeutics, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ
May 20th 2022, 3:05pm
stock_patterns @stock_patterns
$ALDX - Pattern Detected ? Green line shows the recent price movements Red lines shows the similar price movements https://t.co/u9RiWUdLCx
May 20th 2022, 2:05pm
Tickeron @Tickeron
$ALDX's Aroon indicator drops into Downtrend on May 18, 2022. View odds for this and other indicators:… https://t.co/TuOGJJRuTN
May 19th 2022, 7:05pm
MarcJacksonLA @MarcJacksonLA
$ALDX Aldeyra's Dry Eye Candidate Tops Vehicle In Post-Hoc Analysis Using Computer Automated Grading In Ocular Redn… https://t.co/u6UPRnku89
May 18th 2022, 10:05pm
Gambiste1 @Gambiste1
RT @AnthemTrading: $ALDX (2.46) Post-hoc analysis just more evidence this next trial will likely be successful.
May 18th 2022, 9:05pm
AnthemTrading @AnthemTrading
$ALDX (2.46) Post-hoc analysis just more evidence this next trial will likely be successful.
May 18th 2022, 9:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.